MedPath

Magnetic Localization of Sentinel Nodes in Squamous Cell Oral Carcinoma.

Recruiting
Conditions
Diagnostic Value of Sentinel Node Biopsy Guided by Magnetic Probe
Registration Number
NCT06261983
Lead Sponsor
Hospital Donostia
Brief Summary

Sentinel node biopsy has been shown to be a viable alternative to elective neck dissection in the early stages of squamous cell oral carcinoma. The aim of this study was to describe the magnetic localization of sentinel nodes (SN) after peritumoral injection of superparamagnetic iron oxide (SPIO) for treating this type of tumor and to analyze the technique's diagnostic performance in 23 patients. The technique located SNs (with minimal complication) in 95.6 % (22/23) of the patients. Three relapses occurred, one in a patient who had shown negative in magnetic SN location and elective neck dissection. The diagnostic performance of magnetic localization achieved a sensitivity and negative predictive value of 0.80 y 0.94, respectively. Magnetic localization of SNs has been shown to be a reproducible technique that may offer a viable alternative to the conventional technique.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Oral squamous cell carcinoma T1-T2, cN0.
  • Absence of alterations to iron metabolism.
Exclusion Criteria
  • Previous neck surgery.
  • Treatment with iron chelators.
  • Pregnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The diagnostic performance of SNB was analyzed in terms of sensitivity (S), specificity (Sp), negative and positive predictive value (NPV and PPV).Six years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Josué Hernando Vázquez

🇪🇸

Donostia, Guipuzkoa, Spain

Josué Hernando Vázquez
🇪🇸Donostia, Guipuzkoa, Spain
Josué Hernando, PhD, DDS
Contact
0034 675825482
josue.hernando@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.